Results 21 to 30 of about 25,183 (154)

BCG Vaccines

Microbiology Spectrum, 2014
ABSTRACT BCG is the collective name for a family of live attenuated strains of Mycobacterium bovis that are currently used as the only vaccine against tuberculosis (TB). There are two major reasons for studying the genome of these organisms: (i) Because they are attenuated, BCG vaccines provide a window ...
Vanessa, Tran, Jun, Liu, Marcel A, Behr
openaire   +2 more sources

COMPARATIVE ANALYSIS OF THE FREQUENCY AND STRUCTURE OF COMPLICATIONS OF THE BCG AND BCG-M TUBERCULOSIS VACCINE

Žurnal Grodnenskogo Gosudarstvennogo Medicinskogo Universiteta, 2021
Introduction. The effectiveness of TB vaccination is low in more than half of children with tuberculosis, which is confirmed by the small size of the post-vaccination scar or its absence.
Pozdnyakova A. S.
doaj   +1 more source

Tuberculin conversion rate after BCG vaccination of apparently healthy infants in a resource-poor setting

International Journal of Medicine and Health Development, 2022
Background: Although Bacillus Calmette Guerin (BCG) vaccine remains one of the most important public health preventive measures against tuberculosis (TB), the presence of a BCG scar may not imply an immune response.
Eziamaka J Enemuo, Kenechukwu Kosisochukwu Iloh, Agozie C Ubesie, Henrietta U Okafor, Anthony Nnaemeka Ikefuna   +4 more
doaj   +1 more source

Observational study to estimate the changes in the effectiveness of bacillus Calmette–Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK

Health Technology Assessment, 2017
Background: Until recently, evidence that protection from the bacillus Calmette–Guérin (BCG) vaccination lasted beyond 10 years was limited. In the past few years, studies in Brazil and the USA (in Native Americans) have suggested that protection from ...
Punam Mangtani, Patrick Nguipdop-Djomo, Ruth H Keogh, Lucy Trinder, Peter G Smith, Paul EM Fine, Jonathan Sterne, Ibrahim Abubakar, Emilia Vynnycky, John Watson, David Elliman, Marc Lipman, Laura C Rodrigues   +12 more
doaj   +1 more source

COVID-19 and Beyond: Exploring Public Health Benefits from Non-Specific Effects of BCG Vaccination

Microorganisms, 2021
Bacille Calmette–Guérin (BCG) vaccination, widely used throughout the world to protect against infant tuberculous meningitis and miliary tuberculosis (TB), can provide broad non-specific protection against infectious respiratory diseases in certain ...
Kent J. Koster, Hilary L. Webb, Jeffrey D. Cirillo   +2 more
doaj   +1 more source

BCG and Adverse Events in the Context of Leprosy

Frontiers in Immunology, 2018
BackgroundNotwithstanding its beneficial immunoprophylactic outcomes regarding leprosy and childhood TB, BCG vaccination may cause adverse events, particularly of the skin.
Renate Richardus, Renate Richardus, Anouk van Hooij, Susan J. F. van den Eeden, Louis Wilson, Korshed Alam, Jan Hendrik Richardus, Annemieke Geluk   +7 more
doaj   +1 more source

Impact of vaccine platform and BCG vaccination on antibody responses to COVID-19 vaccination

Frontiers in Immunology, 2023
Multiple factors, including vaccine platform and prior vaccinations, influence vaccine responses. We compared antibody responses to CoronaVac (Sinovac) and ChAdOx1-S (AstraZeneca-Oxford) vaccination in 874 healthcare workers in Brazil.
Nicole L. Messina, Nicole L. Messina, Mariana G. Sperotto, Mariana G. Sperotto, Marco A. M. Puga, Marco A. M. Puga, Patricia V. da Silva, Patricia V. da Silva, Roberto D. de Oliveira, Roberto D. de Oliveira, Cecilia L. Moore, Laure F. Pittet, Laure F. Pittet, Laure F. Pittet, Tenaya Jamieson, Margareth Dalcolmo, Margareth Dalcolmo, Glauce dos Santos, Bruno Jardim, Marcus V. G. Lacerda, Nigel Curtis, Nigel Curtis, Nigel Curtis, Julio Croda, Julio Croda, Julio Croda   +25 more
doaj   +1 more source

Neonatal Subcutaneous BCG Vaccination Decreases Atherosclerotic Plaque Number and Plaque Macrophage Content in ApoE^−/− Mice

Biology, 2022
Bacille-Calmette Guérin (BCG) modulates atherosclerosis development in experimental animals, but it remains unclear whether neonatal BCG vaccination is pro- or anti-atherogenic.
Siroon Bekkering, Krishan Singh, Hui Lu, Albert P. Limawan, Claudia A. Nold-Petry, Megan J. Wallace, Nigel Curtis, Salvatore Pepe, Michael Cheung, David P. Burgner, Timothy Moss   +10 more
doaj   +1 more source

Outcome of BCG Vaccination in ADA-SCID Patients: A 12-Patient Series

Biomedicines, 2023
Vaccination with Bacillus Calmette–Guérin (BCG) can be harmful to patients with combined primary immunodeficiencies. We report the outcome of BCG vaccination in a series of twelve patients affected by adenosine deaminase deficiency (ADA-SCID).
Daniele Canarutto, Chiara Oltolini, Federica Barzaghi, Valeria Calbi, Maddalena Migliavacca, Francesca Tucci, Vera Gallo, Giulia Consiglieri, Francesca Ferrua, Salvatore Recupero, Maria Celia Cervi, Hamoud Al-Mousa, Anna Pituch-Noworolska, Chiara Tassan Din, Paolo Scarpellini, Paolo Silvani, Claudia Fossati, Miriam Casiraghi, Daniela Maria Cirillo, Antonella Castagna, Maria Ester Bernardo, Alessandro Aiuti, Maria Pia Cicalese   +22 more
doaj   +1 more source

A longitudinal study of BCG vaccination in early childhood: the development of innate and adaptive immune responses.

PLoS ONE, 2010
BCG vaccine drives a strong T helper 1 cellular immunity which is essential for the protection against mycobacteria, however recent studies suggest that BCG vaccination can have non-specific beneficial effects unrelated to tuberculosis.
Yenny Djuardi, Erliyani Sartono, Heri Wibowo, Taniawati Supali, Maria Yazdanbakhsh   +4 more
doaj   +1 more source